发明名称 Anthrax lethal factor is a MAPK kinase protease
摘要 The present invention relates to in vitro and ex vivo methods of screening for modulators, homologues, and mimetics of lethal factor mitogen activated protein kinase kinase (MAPKK) protease activity, as well as methods of treating cancer by administering LF to transformed cells.
申请公布号 US6911203(B2) 申请公布日期 2005.06.28
申请号 US20020093200 申请日期 2002.03.05
申请人 发明人
分类号 C12Q1/00;C12Q1/37;(IPC1-7):A61K38/46;A01N63/00;C12N9/52;C12N15/63;C12Q1/40 主分类号 C12Q1/00
代理机构 代理人
主权项
地址